The Scientific Advisory Team at Owkin plays a critical role in guiding the company's research and development strategies. Comprised of expert scientific advisors, the team provides insights and recommendations on leveraging AI for drug development and patient care in oncology. They ensure scientific rigor and relevance in Owkin's projects, collaborating with prominent cancer centers and pharmaceutical companies to optimize outcomes and advance medical research.
Fabrice André
Scientific Advisor
Jakob Nikolas Kather
Scientific Advisor
Jean-Yves Blay
Scientific Advisor
Miriam Merad
Scientific Advisor
Nicolas Girard
Scientific Advisor
Olivier Elemento
Scientific Advisor
Raphaël Rousseau
Scientific Advisor
Roger Stupp
Scientific Advisor
Shahrokh Shariat
Scientific Advisor